Sublimity Therapeutics – Funding to Develop New Drug

Irish Times – Irish pharma company closes $64m financing round

Please link to the article by Charlie Taylor below which was posted in May 2018 by irishtimes.com/business website.

Sigmoid Pharma – now known as Sublimity Therapeutics has closed an enormous $64m round of financing. This large investment is to fund the clinical development of a drug to treat patients with moderate to severe ulcerative colitis. The drug is a soluble formulation which has been indicated as a safe, effective treatment for several inflammatory diseases including psoriasis and Crohn’s disease.

You can access further information reading the full article by clicking on the button below.

Irish Times – “Irish pharma company closes $64m financing round”

Recent Posts

News Archive

If you are interested in becoming an Investor or seeking investment, then please contact us.

2018-07-19T14:50:26+00:00